JP2009502985A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009502985A5 JP2009502985A5 JP2008524341A JP2008524341A JP2009502985A5 JP 2009502985 A5 JP2009502985 A5 JP 2009502985A5 JP 2008524341 A JP2008524341 A JP 2008524341A JP 2008524341 A JP2008524341 A JP 2008524341A JP 2009502985 A5 JP2009502985 A5 JP 2009502985A5
- Authority
- JP
- Japan
- Prior art keywords
- viral infection
- treatment
- prevention
- acid ester
- pharmaceutical intermediate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 208000036142 Viral infection Diseases 0.000 claims 15
- 230000009385 viral infection Effects 0.000 claims 15
- -1 hydroxybenzoic acid ester Chemical class 0.000 claims 12
- 239000012450 pharmaceutical intermediate Substances 0.000 claims 12
- 230000002265 prevention Effects 0.000 claims 11
- 150000001875 compounds Chemical class 0.000 claims 4
- 238000002360 preparation method Methods 0.000 claims 4
- 208000000260 Warts Diseases 0.000 claims 2
- 239000004480 active ingredient Substances 0.000 claims 2
- 239000002671 adjuvant Substances 0.000 claims 2
- LNTHITQWFMADLM-UHFFFAOYSA-N anhydrous gallic acid Natural products OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 claims 2
- 239000000543 intermediate Substances 0.000 claims 2
- 239000000203 mixture Substances 0.000 claims 2
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 claims 2
- BRRSNXCXLSVPFC-UHFFFAOYSA-N pyrogallocarboxylic acid Natural products OC(=O)C1=CC=C(O)C(O)=C1O BRRSNXCXLSVPFC-UHFFFAOYSA-N 0.000 claims 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 claims 2
- 201000010153 skin papilloma Diseases 0.000 claims 2
- 239000000344 soap Substances 0.000 claims 2
- 239000000243 solution Substances 0.000 claims 2
- 239000003826 tablet Substances 0.000 claims 2
- 210000001519 tissue Anatomy 0.000 claims 2
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 claims 1
- 125000004209 (C1-C8) alkyl group Chemical group 0.000 claims 1
- GPDXFYPVHRESMA-UHFFFAOYSA-N 2,4,5-trihydroxybenzoic acid Chemical compound OC(=O)C1=CC(O)=C(O)C=C1O GPDXFYPVHRESMA-UHFFFAOYSA-N 0.000 claims 1
- 229940090248 4-hydroxybenzoic acid Drugs 0.000 claims 1
- 208000009889 Herpes Simplex Diseases 0.000 claims 1
- 241001465754 Metazoa Species 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 claims 1
- 208000009608 Papillomavirus Infections Diseases 0.000 claims 1
- 208000006374 Uterine Cervicitis Diseases 0.000 claims 1
- 206010046914 Vaginal infection Diseases 0.000 claims 1
- 201000008100 Vaginitis Diseases 0.000 claims 1
- 241000700605 Viruses Species 0.000 claims 1
- 125000000217 alkyl group Chemical group 0.000 claims 1
- 229940114055 beta-resorcylic acid Drugs 0.000 claims 1
- UIAFKZKHHVMJGS-UHFFFAOYSA-N beta-resorcylic acid Natural products OC(=O)C1=CC=C(O)C=C1O UIAFKZKHHVMJGS-UHFFFAOYSA-N 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- 239000002775 capsule Substances 0.000 claims 1
- 206010008323 cervicitis Diseases 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 230000002500 effect on skin Effects 0.000 claims 1
- 230000003628 erosive effect Effects 0.000 claims 1
- 239000008187 granular material Substances 0.000 claims 1
- 208000002672 hepatitis B Diseases 0.000 claims 1
- 150000005165 hydroxybenzoic acids Chemical class 0.000 claims 1
- 238000002347 injection Methods 0.000 claims 1
- 239000007924 injection Substances 0.000 claims 1
- 239000007788 liquid Substances 0.000 claims 1
- 239000006210 lotion Substances 0.000 claims 1
- 210000004877 mucosa Anatomy 0.000 claims 1
- 239000007922 nasal spray Substances 0.000 claims 1
- 229940097496 nasal spray Drugs 0.000 claims 1
- 239000002674 ointment Substances 0.000 claims 1
- 239000000825 pharmaceutical preparation Substances 0.000 claims 1
- 229940127557 pharmaceutical product Drugs 0.000 claims 1
- 239000000843 powder Substances 0.000 claims 1
- YQUVCSBJEUQKSH-UHFFFAOYSA-N protochatechuic acid Natural products OC(=O)C1=CC=C(O)C(O)=C1 YQUVCSBJEUQKSH-UHFFFAOYSA-N 0.000 claims 1
- 229960004889 salicylic acid Drugs 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 239000007921 spray Substances 0.000 claims 1
- 230000001954 sterilising effect Effects 0.000 claims 1
- 238000004659 sterilization and disinfection Methods 0.000 claims 1
- 239000000829 suppository Substances 0.000 claims 1
- 210000002303 tibia Anatomy 0.000 claims 1
- 238000005406 washing Methods 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005100122870A CN100427082C (zh) | 2005-08-02 | 2005-08-02 | 羟基苯甲酸酯及其类似物在制备预防和治疗病毒性感染药物中的应用 |
| CN200510012287.0 | 2005-08-02 | ||
| PCT/CN2006/001792 WO2007014515A1 (en) | 2005-08-02 | 2006-07-21 | Use of hydroxybenzoic acid ester and analogues for the manufacture of a mendicament for the prevention and treatment of virus infection |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2009502985A JP2009502985A (ja) | 2009-01-29 |
| JP2009502985A5 true JP2009502985A5 (enExample) | 2009-09-03 |
| JP5473328B2 JP5473328B2 (ja) | 2014-04-16 |
Family
ID=37698614
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008524341A Expired - Lifetime JP5473328B2 (ja) | 2005-08-02 | 2006-07-21 | ウイルス感染の予防および治療用の薬剤の製造のためのヒドロキシ安息香酸エステルおよび類似体の使用 |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP1930002B1 (enExample) |
| JP (1) | JP5473328B2 (enExample) |
| KR (1) | KR100922605B1 (enExample) |
| CN (1) | CN100427082C (enExample) |
| AP (1) | AP2658A (enExample) |
| AU (1) | AU2006275232B2 (enExample) |
| BR (1) | BRPI0616536B8 (enExample) |
| CA (1) | CA2617659C (enExample) |
| CY (1) | CY1117480T1 (enExample) |
| DK (1) | DK1930002T3 (enExample) |
| EA (1) | EA016576B1 (enExample) |
| ES (1) | ES2567130T3 (enExample) |
| HU (1) | HUE027244T2 (enExample) |
| IL (1) | IL189162A (enExample) |
| MX (1) | MX2008001673A (enExample) |
| NZ (1) | NZ566153A (enExample) |
| PL (1) | PL1930002T3 (enExample) |
| SI (1) | SI1930002T1 (enExample) |
| UA (1) | UA90159C2 (enExample) |
| WO (1) | WO2007014515A1 (enExample) |
| ZA (1) | ZA200801635B (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102603522B (zh) * | 2011-01-23 | 2015-04-22 | 复旦大学 | 苯酚类衍生物及其在制备抗乙肝病毒药物中的用途 |
| KR101401154B1 (ko) * | 2011-02-22 | 2014-05-30 | 경희대학교 산학협력단 | 메틸 갈레이트를 포함하는 조절 ｔ 세포 활성 억제용 약학적 조성물 |
| PL404138A1 (pl) * | 2013-05-31 | 2014-12-08 | Warszawski Uniwersytet Medyczny | Pochodne kwasu benzoesowego jako inhibitory receptora IL-15Rα |
| CN103599093B (zh) | 2013-11-18 | 2016-06-01 | 中国医学科学院生物医学工程研究所 | 一种抗hpv药物制剂及用途 |
| CN103948729B (zh) * | 2014-05-15 | 2015-09-09 | 陈欣 | 一种治疗宫颈糜烂的中药栓剂及其制备方法 |
| CA3008466C (en) | 2015-12-18 | 2023-06-20 | Talengen International Limited | Method for preventing or treating radiation and chemical damage |
| EP3395355B1 (en) * | 2015-12-18 | 2026-03-04 | Talengen International Limited | Plasminogen for use in treating cervical erosion |
| CN105748506B (zh) * | 2016-03-03 | 2018-08-17 | 青岛海洋生物医药研究院股份有限公司 | 褐藻酸硫酸酯在制备预防和治疗由人乳头瘤状病毒引起的疾病的药物和保健品中的应用 |
| JPWO2019087884A1 (ja) * | 2017-10-31 | 2020-11-19 | 富士フイルム株式会社 | 組成物、抗菌組成物、抗ウイルス用組成物、抗ノロウイルス用組成物、スプレー、ワイパー |
| JPWO2019087881A1 (ja) * | 2017-10-31 | 2020-10-22 | 富士フイルム株式会社 | 抗ウイルス用組成物、抗ノロウイルス用組成物、スプレー、ワイパー |
| JPWO2019087888A1 (ja) * | 2017-10-31 | 2020-11-12 | 富士フイルム株式会社 | 組成物、抗菌組成物、抗ウイルス用組成物、抗ノロウイルス用組成物、スプレー、ワイパー |
| CN111419833B (zh) * | 2020-06-02 | 2023-04-07 | 上海爱启医药技术有限公司 | 没食子酸的药物应用 |
| CN114146078B (zh) * | 2020-09-07 | 2025-09-16 | 盈科瑞（横琴）药物研究院有限公司 | 对羟基苯甲酸乙酯抗冠状病毒感染的应用 |
| CN114146082B (zh) * | 2020-09-07 | 2025-09-05 | 盈科瑞（横琴）药物研究院有限公司 | 对羟基苯甲酸甲酯及其钠盐抗冠状病毒的用途 |
| CN112375803B (zh) * | 2020-11-16 | 2024-05-07 | 石河子大学 | 五倍子中抗炎活性成分没食子酸乙酯的筛选方法及其用途 |
| CN118489806A (zh) * | 2024-05-13 | 2024-08-16 | 浙江大学 | 多酚在制备预防和/或缓解动物锌过载所致肠道免疫应激或肠道损伤制剂中的应用 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3929985A (en) * | 1974-01-18 | 1975-12-30 | Richardson Merrell Inc | Anhydrous candicidin foam compositions |
| JPS62132824A (ja) * | 1985-12-05 | 1987-06-16 | Eisai Co Ltd | 肝炎への治療剤 |
| SE464167B (sv) * | 1989-07-31 | 1991-03-18 | Analytecon Sa | Topisk farmaceutisk beredning av podophyllotoxin |
| CN1042298C (zh) * | 1989-07-31 | 1999-03-03 | 安纳利蒂康有限公司 | 含鬼臼毒的乳膏形式的药物组合物的制备方法 |
| CN1068782A (zh) * | 1992-01-30 | 1993-02-10 | 展静 | 轮胎气压报警装置 |
| NL9500216A (nl) * | 1995-02-06 | 1996-09-02 | Bio Pharma Sciences Bv | Farmaceutische samenstelling voor de behandeling van herpes. |
| DE19514694A1 (de) * | 1995-04-13 | 1996-10-17 | Ina Dr Levi | Breitspektrum-Antiinfektivamittel |
| JPH0959151A (ja) * | 1995-08-24 | 1997-03-04 | Kao Corp | ＮＦ−κＢ活性化抑制剤 |
| CN1068782C (zh) * | 1996-04-18 | 2001-07-25 | 中国医药研究开发中心 | 以栾树提取物为有效组分的抗癌药物及制备方法 |
| JPH09328404A (ja) * | 1996-06-07 | 1997-12-22 | Iwao Hishida | 殺菌、抗菌および不活化剤 |
| TW536403B (en) * | 1997-03-24 | 2003-06-11 | Glaxo Group Ltd | An ethanol and ethylenediaminetetraacetic acid free pharmaceutical composition comprising lamivudine and exhibiting antimicrobial preservative efficacy |
| KR20010013377A (ko) | 1997-06-04 | 2001-02-26 | 데이비드 엠 모이어 | 마일드한 잔류성 항균 조성물 |
| DK1383512T3 (da) * | 2001-05-03 | 2004-11-15 | Farmigea Spa | Anvendelse af sucralfat til behandling af cervikal erosion |
-
2005
- 2005-08-02 CN CNB2005100122870A patent/CN100427082C/zh not_active Expired - Lifetime
-
2006
- 2006-07-21 JP JP2008524341A patent/JP5473328B2/ja not_active Expired - Lifetime
- 2006-07-21 EP EP06761527.8A patent/EP1930002B1/en not_active Expired - Lifetime
- 2006-07-21 BR BRPI0616536A patent/BRPI0616536B8/pt not_active IP Right Cessation
- 2006-07-21 SI SI200632042A patent/SI1930002T1/sl unknown
- 2006-07-21 EA EA200800467A patent/EA016576B1/ru unknown
- 2006-07-21 AP AP2008004351A patent/AP2658A/xx active
- 2006-07-21 KR KR1020087005140A patent/KR100922605B1/ko not_active Expired - Fee Related
- 2006-07-21 CA CA2617659A patent/CA2617659C/en not_active Expired - Lifetime
- 2006-07-21 PL PL06761527T patent/PL1930002T3/pl unknown
- 2006-07-21 DK DK06761527.8T patent/DK1930002T3/en active
- 2006-07-21 MX MX2008001673A patent/MX2008001673A/es active IP Right Grant
- 2006-07-21 NZ NZ566153A patent/NZ566153A/en not_active IP Right Cessation
- 2006-07-21 UA UAA200802626A patent/UA90159C2/ru unknown
- 2006-07-21 AU AU2006275232A patent/AU2006275232B2/en not_active Ceased
- 2006-07-21 ES ES06761527.8T patent/ES2567130T3/es not_active Expired - Lifetime
- 2006-07-21 WO PCT/CN2006/001792 patent/WO2007014515A1/zh not_active Ceased
- 2006-07-21 HU HUE06761527A patent/HUE027244T2/en unknown
-
2008
- 2008-01-31 IL IL189162A patent/IL189162A/en active IP Right Grant
- 2008-02-19 ZA ZA200801635A patent/ZA200801635B/xx unknown
-
2016
- 2016-04-05 CY CY20161100272T patent/CY1117480T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009102342A5 (enExample) | ||
| CA2617659A1 (en) | Use of hydroxybenzoic acid esters and analogues for the manufacture of a medicament for the prevention and treatment of virus infection | |
| RU2329050C2 (ru) | Комбинация ингибиторов цитохром-р450-зависимых протеаз | |
| JP2009535352A5 (enExample) | ||
| US20100137222A1 (en) | Basic Peptides and Their Use as Combined Antibacterial-Antifungine Agents | |
| US20160151436A1 (en) | Treatment of Herpes, Pseudomonas, Staph, and Hepatitis | |
| JP2011046708A5 (enExample) | ||
| AU781066B2 (en) | Pharmacological agent comprising picolinic acid, fusaric acid and derivatives thereof | |
| JP2012508256A5 (enExample) | ||
| JP2023110038A (ja) | ワクチンを使用して癌または皮膚病変を治療するための方法および組成物 | |
| RU2008110933A (ru) | Применение амброксола для лечения риновирусных инфекций | |
| JP2023529025A5 (enExample) | ||
| CN111358779A (zh) | 苦杏碱醇a在防治新型冠状病毒感染中的应用 | |
| JP2007534731A5 (enExample) | ||
| WO2022123323A1 (en) | A pharmaceutical composition of artesunate and mefloquine and method thereof | |
| ES3002532T3 (en) | Application of dalargin for the prevention of viral respiratory infections and prevention of the development of complications during viral respiratory infections | |
| WO2023134733A1 (en) | Treatment of signs, symptoms and/or complications of viral, bacterial, protozoal, and/or fungal infections by high penetration prodrugs | |
| RU2023125283A (ru) | Фармацевтические композиции, содержащие флурбипрофен | |
| US20060287364A1 (en) | Methods of prevention of infection with HIV/AIDS, venereal disease and influenza | |
| RU2008147222A (ru) | Фармацевтическая композиция, обладающая противовоспалительным, в частности противоастматическим действием, применения фармацевтической композиции (варианты) и лекарственное средство (варианты) | |
| TW202535906A (zh) | 新型短鏈肽及其衍生物 | |
| JP6871760B2 (ja) | 抗ウイルス作用促進用組成物 | |
| JP2022132181A (ja) | コロナウイルスの細胞侵入抑制剤 | |
| EA048350B1 (ru) | Применение даларгина для профилактики орви и предотвращения развития осложнений при заболеваниях орви | |
| TH83579B (th) | สารผสม |